Kairon Health is an AI execution platform for value-based care organizations, including ACOs, health systems and physician groups. It combines claims, clinical and operational data to identify care gaps, create prioritized staff worklists and patient outreach, then tracks completed actions and measurable outcomes across Medicare and commercial care programs.
GA
General Advance
Activity from announced rounds
Activity in this selectionOct 17, 2026 · Jul 20, 2026
General Advance is a private technology investment firm identified in Kairon Health and Pharosyn materials.
Recorded funding activity
Kairon develops execution software for value-based care operations. Pharosyn turns pharmaceutical market and regulatory signals into traceable reports, while Multiplier builds agent systems for asset managers’ research. These businesses serve different professional decisions.
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $14M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionKairon Health
$5MSeed
ParticipantPharosyn
AI-powered commercial intelligence for pharmaceutical teams, turning clinical, regulatory and market signals into traceable reports and decision support.
$3MSeed
ParticipantMultiplier
Builds AI agent harnesses for asset managers' proprietary research and data
$6MSeed
Role not disclosed